Cell Signaling Technology is proud to partner with the Koch Institute at MIT, Science, and Science Signaling to present the Targeting Cancer Pathways webinar series. These webinars bring together thought leaders from around the world to share current findings and further cancer research community collaboration.
In this webinar the speakers examine how rewiring of signaling pathways in response to drug treatment contributes to tumor resistance and how this knowledge can inform the development of more effective treatment strategies.